Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de James J. Collins
Vermogen : 1 097 659 USD
Belangrijkste bedrijven : Fulcrum Therapeutics, Inc. - Orion Biotech Opportunities Corp.
Overzicht 
Founder of 8 different companies, among them: Synlogic, Inc., Corvium, Inc. and Sherlock Biosciences, Inc. James J. Collins is an entrepreneur is Professor at Harvard University, Professor at Massachusetts Institute of Technology, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Engineering, Member of Harvard Mit Health Sciences & Technology and Member of National Academy of Medicine of United States and on the board of 5 other companies.

He previously was Chief Scientific Officer for GNS Healthcare, Inc. and Professor at Boston University.

Dr. Collins received an undergraduate degree from College of the Holy Cross (Massachusetts) and a doctorate from the University of Oxford.


Posities en verantwoordelijkheden van James J. Collins 
NaamTitel Van
Fulcrum Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2017
Orion Biotech Opportunities Corp.
(Holdingvennootschappen)
Independent Director -
National Academy of Inventors Member -
Sherlock Biosciences, Inc. Director -
Cellarity Inc. Director 2017
Harvard University Professor -
Massachusetts Institute of Technology Professor 2014
National Academy of Sciences Member -
American Academy of Arts & Sciences Member -
National Academy of Engineering Member -
Harvard Mit Health Sciences & Technology Member -
National Academy of Medicine of United States Member -
Synlogic Operating Co., Inc. Co-Founder 2014


Belangnemingen van James J. Collins 
NaamAandelen%Totale waarde
Fulcrum Therapeutics, Inc. (FULC)
(Biotechnologie & Medisch Onderzoek)
23 5710,058%700 059 USD
Orion Biotech Opportunities Corp.40 0000,80%397 600 USD


James J. CollinsPersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
James J. Collins Verbindingen